Healthcare -
Biotechnology - NASDAQ - GB
$ 2.97
1.37 %
$ 460 M
Market Cap
-9.9
P/E
MREO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MREO - Mereo BioPharma Group plc
7.97 M
LAST VALUE
-67.96%
2 YEAR CAGR
42.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR